跳至主要内容
临床试验/IRCT20180313039085N1
IRCT20180313039085N1已完成3 期

Evaluation of the effect of letrozole in the prevention of ovarian hyperstimulation syndrome in patients at risk of treatment with ovulation-stimulating drugs

Esfahan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • Candidate for treatment with ovarian superovulation drugs
  • history of one year of infertility at least
  • Body mass index less than 25 kg/m2
  • Antimullerian hormone levels higher than 5 ng/ml

排除标准

  • History of any hormone therapy during the previous three months
  • History of allergy to letrozole and other aromatase inhibitors
  • History of heart disease
  • History of kidney disease
  • History of liver disease
  • History of endocrine diseases

研究者

相似试验